MedPath

Diprivan

Diprivan 1% Injection Emulsion (propofol) 10 mg/mL Injectable Emulsion 50 mL Vial

Approved
Approval ID

7603f1ba-cfbd-4ec5-881a-13f4832c9893

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 18, 2017

Manufacturers
FDA

General Injectables & Vaccines, Inc

DUNS: 108250663

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Diprivan

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code52584-269
Application NumberNDA019627
Product Classification
M
Marketing Category
C73594
G
Generic Name
Diprivan
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJanuary 18, 2017
FDA Product Classification

INGREDIENTS (1)

PropofolActive
Quantity: 10 mg in 1 mL
Code: YI7VU623SF
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Diprivan - FDA Drug Approval Details